What is it about?
Both Metabolic Syndrome and Rheumatoid Arthritis share inflammation as a common cause. Therefore, patients with the latter condition must be screened for the former. This article reviews this association, gives valuable insight into its management, and discusses the latest research in the field.
Featured Image
Photo by JK Sloan on Unsplash
Why is it important?
When doctors see patients with Rheumatoid arthritis early in its course they should proactively screen for the Metabolic syndrome. Doing so will reduce the burden of additional suffering due to heart attacks and strokes in these patients. This will not only reduce suffering but will improve quality of life.
Perspectives
Read the Original
This page is a summary of: Metabolic Syndrome and its Outcomes in Rheumatoid Arthritis: A Review, EMJ Rheumatology, January 2022, European Medical Group,
DOI: 10.33590/emjrheumatol/22-00125.
You can read the full text:
Resources
Contributors
The following have contributed to this page